Posted Apr. 2, 2014 at 9:39 a.m.

Premium Lock Scynexis sharply lowers target price for stock in IPO, doubles number of shares

Published: 2014-04-02 09:39:00
Updated: 2014-04-02 09:39:00

Scynexis

The Durham-based drug firm has finalized plans to begin selling shares between $7 and $8 on Thursday on the Nasdaq under the symbol SCYX. That's well under an earlier targeted range of between $12 and $14 a share. Scynexis also is doubling the number of shares available....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Scroll